Outsourced products
Tetraxim Inj.
- ClassificationPrescription Drug
- Therapeutics classificationBACTERIAL AND VIRAL VACCINES, COMBINED (DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS)
- ManufacturerSanofi-Aventis Korea
A pre-filled syringe containing a white suspension
Diphtheria Toxoid (Strain: 1514-N-3S) ≥30 IU, Tetanus Toxoid (Strain: 1472-C) ≥40 IU, Pertussis Toxoid (Strain: 1591) 25 μg, Filamentous Hemagglutinin (FHA) (Strain: 1591) 25 μg, Inactivated Poliovirus Type I (Strain: Mahoney) 40 DU, Inactivated Poliovirus Type II (Strain: MEF-1) 8 DU, Inactivated Poliovirus Type III (Strain: Saukett) 32 DU in one pre-filled syringe (0.5mL)
Prevention of diphtheria, tetanus, pertussis, and poliomyelitis (polio)
Primary Immunization: Administer 3 doses of 0.5 mL each at 2, 4, and 6 months of age.
Booster Dose: Administer a single dose of 0.5 mL at 4~6 years of age.
Administer intramuscularly. Never administer intravenously.
For children under 2 years of age, inject into the anterolateral thigh; for children 5 years of age and older, inject into the deltoid muscle.
1 pre-filled syringe/box [Pre-filled syringe (0.5 mL)]
1 sterile needle
Store in a tightly closed container at 2~8℃, protected from light. Avoid freezing.